In 2024, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

Balanced testosterone levels are essential to fertility, well-being, and general health. Learn the symptoms, causes, and ...

This represents a burgeoning American health trend. Between 2019 and 2024 prescriptions for testosterone jumped from 7.3m to ...

Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business. Grünenthal is ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA ...